Active Ingredient: DIFELIKEFALIN ACETATE
Proprietary Name: KORSUVA
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 0.065MG BASE/1.3ML (EQ 0.05MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214916
Product Number: 001
Approval Date: Aug 23, 2021
Applicant Holder Full Name: CARA THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information